Inventor · disambiguated record
Emile Bellott
Also filed as: BELLOTT EMILE · BELLOTT EMILE M · BELLOTT JR EMILE M
12 granted patents·5 pending applications·2,384 citations·filing 1983–2013
93Inventor score
Files withBIOFRONTERA BIOSCIENCE GMBH2CHILDRENS MEDICAL CENTER2INTERNEURON PHARMA2MASIMO LABORATORIES INC2NUCHEM PHARMACEUTICALS INC2
Top patents by PatentIndex Score
17 records- 0197US8029765B2SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensorsMASIMO LABORATORIES INC·Filed 2004·Granted Oct 4, 2011·696 cites·11 claims
- 0297US8008088B2SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensorsMASIMO LABORATORIES INC·Filed 2006·Granted Aug 30, 2011·852 cites·6 claims
- 0395US8466286B2SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensorsBELLOTT EMILE M·Filed 2011·Granted Jun 18, 2013·640 cites·13 claims
- 0490US5403851ASubstituted tryptamines, phenalkylamines and related compoundsINTERNEURON PHARMA·Filed 1994·Granted Apr 4, 1995·93 cites·17 claims
- 0588US7060711B2Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonistBIOFRONTERA BIOSCIENCE GMBH·Filed 2002·Granted Jun 13, 2006·24 cites·10 claims
- 0686US5580878ASubstituted tryptamines phenalkylamines and related compoundsINTERNEURON PHARMA·Filed 1995·Granted Dec 3, 1996·66 cites·8 claims
- 0766US2014127137A1Smmr (small molecule metabolite reporters) for use as in vivo glucose biosensorsCERCACOR LAB INC·Filed 2013·Application pending·0 cites
- 0864US6800658B2Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferationCHILDRENS MEDICAL CENTER·Filed 2002·Granted Oct 5, 2004·3 cites·16 claims
- 0956US7511064B2Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonistBIOFRONTERA BIOSCIENCE GMBH·Filed 2006·Granted Mar 31, 2009·0 cites·21 claims
- 1052US2002119953A1Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory diseaseFiled 2001·Application pending·0 cites
- 1150US7342038B2Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferationHARVARD COLLEGE·Filed 2004·Granted Mar 11, 2008·0 cites·15 claims
- 1247US2003191111A1Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferationCHILDRENS MEDICAL CENTER·Filed 2003·Application pending·0 cites
- 1345US2002128256A1Methods for the treatment or prevention of inflammatory diseases characterized by abnormal cell proliferationFiled 2001·Application pending·0 cites
- 1444US4454200AMethods for conducting electron beam lithographyVARIAN ASSOCIATES·Filed 1983·Granted Jun 12, 1984·7 cites·19 claims
- 1537US2003022920A11-Methyl-4- (3-ethoxy-9H-thioxanthene-9-ylidene) -piperidine and its use as 5-HT2B/H1 receptor antagonistFiled 2002·Application pending·0 cites
- 1634US6992079B2Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferationNUCHEM PHARMACEUTICALS INC·Filed 2001·Granted Jan 31, 2006·0 cites·22 claims
- 1734US6534497B1Substitute 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferationNUCHEM PHARMACEUTICALS INC·Filed 1998·Granted Mar 18, 2003·3 cites·29 claims
Join the waitlist — get patent alerts
Get an alert when Emile Bellott files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →